Alteogen posted a modest rebound, putting its recent price correction behind it. On the 4th, Alteogen closed at 288,500 won, up 5,500 won from the previous trading day, a gain of 1.94%. Rather than a sharp rally, the move was closer to a partial recovery of losses as buying interest flowed in at the upper 280,000-won range.

■ Intraday swings around the 290,000-won level... trading value of 177.5 billion won

The stock opened at 290,500 won and fluctuated around the 290,000-won level, recording an intraday high of 294,000 won and a low of 284,250 won before ultimately closing in the upper 280,000-won range. Trading volume came to 613,855 shares, with trading value totaling about 177.5 billion won. Amid recently widened price volatility, the stock saw considerable trading activity.

■ Still high compared to 52-week low... market cap of 20.0955 trillion won

Alteogen's 52-week high is 437,818 won and its 52-week low is 194,671 won. While the current share price remains far below the yearly peak, it is holding at a high level compared to the low. Its market capitalization stands at approximately 20.0955 trillion won, with foreign ownership at 14.4%.

■ Valuation of PER 105.52x and PBR 37.73x

In terms of valuation metrics, the price-to-earnings ratio (PER) was 105.52, with earnings per share (EPS) of 2,734 won. The estimated PER is 68.69 and estimated EPS is 4,200 won. The price-to-book ratio (PBR) is 37.73, with book value per share (BPS) at 7,646 won.

■ Short-term key is settling above 290,000 won... support in mid-280,000 range also needs confirmation

As a stock that has drawn growth expectations based on its bio platform technology, Alteogen's future share price trajectory is likely to hinge on variables such as earnings improvement, technology transfer outcomes, and further business progress.

In the short term, the focus is on whether the stock can establish itself above the 290,000-won level. Although it rose as high as 294,000 won intraday, it failed to close above 290,000 won. Meanwhile, with the day's low formed at 284,250 won, whether support holds in the mid-280,000-won range also needs to be confirmed.

Another variable is the growing price volatility across bio stocks in general. Share price swings could widen not only on individual companies' business performance but also on interest rates, market supply and demand, and shifts in investor sentiment, so it is advisable to look at actual earnings and business progress rather than short-term fluctuations.

[※ This article was written to provide information on the domestic stock market and the relevant stock, and does not recommend buying or selling any specific stock or guarantee investment returns. Stock prices can fluctuate significantly depending on domestic and overseas market conditions, corporate earnings, supply and demand, and various other factors, and investors may lose part or all of their principal. Investment decisions and the responsibility for them rest with the investor, and investors are advised to thoroughly review corporate disclosures and market conditions before investing. This article was written with AI assistance.]